Matches 1 - 23 out of 23


Match Document Document Title
DE102007007644A1 New aminocoumarin compounds, designated novclobiocins, useful as broad-spectrum antibiotics and cytotoxic agents, prepared sing genetically modified bacterial strains  
New aminocoumarin compounds (I), designated novclobiocins, consist of clorobiocin analogs containing modified N-acyl residues and/or 8-substituents. Aminocoumarin compounds of formula (I) are new....
DE102007002386A1 Pharmaceutically active compounds  
The present invention relates to pharmaceutically active compounds from an isoflavone or isoflavone glycoside and covalently with this connected, an amino acid, a peptide or peptide derivative...
DE19922287B4 Using Flavonoidestern in cosmetics  
use Flavonoidesters one consisting of the reaction product of a. at least one flavonoid component selected from a flavonoid with a keto group in position 4, a salt of the flavonoid, a Esters of...
DE102004002787A1 Flavonoid complexes  
The Invention relates to complexes of certain flavonoid derivatives, preparations, containing such derivatives, corresponding methods for producing the containing flavonoid derivatives or of these...
DE10240923A1 Flavonoid derivatives for eczema treatment  
It is the use of certain flavonoid derivatives for the preparation of formulations described suitable for the prophylaxis and / or therapy of eczema. In particular, the preparations are suitable...
DE10232595A1 Light stabilizers  
The invention relates to a preparation having light-protection properties, comprising at least one compound of formula I where R1 and R2 are selected from H and OR11Wherein OR11 is independently...
DE10123503A1 Use of Belamcanda chinensis extract, or its active ingredient, for treating sex hormone-dependent urogenital disorders and prostatic hyperplasia  
Use of extract of Belamcanda chinensis to prepare an estrogen-like, organ-selective composition, with little or no uterotropic activity, for treating sex hormone-dependent disorders of the...
DE10019235A1 New flavone derivatives for use in cosmetics, pharmaceuticals and food  
The invention relates to flavone and isoflavone glycoside derivatives of general formula (I): [A1-C(=O)O]m-[X-O-Z]-[O-C(=O)-A2]n (I), wherein [X-O-Z] represents a flavone or isoflavone glycoside...
DE19850572A1 Preparation of new or known luteolin compounds by reducing flavonoids with sodium dithionite, used e.g. as nutritional supplements, cosmetic UV filters or cardiovascular drugs  
Preparation of luteolin (or its O-(hydroxyalkyl) derivatives) (I) involves reducing a flavonoid (II) containing a disaccharide residue, using sodium dithionite in aqueous alkaline medium. Some...
DE19850570A1 Production of new or known tri-O-hydroxyalkyl quercetin or isoquercetin derivatives, e.g. useful as food supplements, comprises enzymatic hydrolysis of tri-O-hydroxyalkyl rutin derivatives in an aqueous medium  
The production of tri-O-hydroxyalkyl quercetin or isoquercetin derivatives (I) comprises enzymatic hydrolysis of tri-O-hydroxyalkyl rutin derivatives (II) in an aqueous medium. The production of...
DE19850283A1 Preparation of new or known luteolin compounds by reducing flavonoids with sodium dithionite, used e.g. as nutritional supplements, cosmetic UV filters or cardiovascular drugs  
Preparation of luteolin (or its O-(hydroxyalkyl) derivatives) (I) involves reducing a flavonoid (II) containing a disaccharide residue, using sodium dithionite in aqueous alkaline medium. Some...
DE19850282A1 Preparation of new or known tris-hydroxyalkyl quercetin and isoquercetin derivatives by enzymatic cleavage of rutin derivatives, used e.g. as nutritional supplements, cosmetic UV filters or cardiovascular drugs  
Preparation of tris-hydroxyalkyl quercetin or isoquercetin derivatives (I) involves enzymatic cleavage of a tris-hydroxyalkyl rutin compound (II) containing a disaccharide residue. Some (I), i.e....
DE19922287A1 Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters  
Cosmetic, dermatological, pharmaceutical, dietetic or agricultural feed composition comprises one or more flavonoid esters (I) in a vehicle, extender or carrier, where (I) are products obtained by...
DE19821038A1 New acarviosin glycoside, prepared by biotransformation of acarbose, used as saccharase inhibitor for treating diabetes  
A new glycoside (I) is formed from the acarviosin of acarbose and rutin.- DETAILED DESCRIPTION - The glycoside of formula (I) is new.- An INDEPENDENT CLAIM is included for the preparation of (I).-...
DE19807774A1 Use of flavone, flavanone or flavonoid compound for protection of ascorbic acid or ascorbyl compound against oxidation, especially in cosmetic and dermatological preparations,  
Use of a flavone (IA), flavanone (IB) and/or flavonoid (IC) to protect ascorbic acid or ascorbyl compounds against oxidation, including photo-oxidation is claimed.
DE19740879A1 Use of flavone derivatives for controlling bacteria  
Use of cosmetically or pharmaceutically acceptable flavone derivatives, especially flavonoids, for combatting or inhibiting the growth of Gram-positive, especially coryneform, bacteria is new.
DE19742025A1 Use of flavone or flavanone derivatives to treat or prevent undesirable skin pigmentation  
The use of cosmetically or pharmaceutically acceptable flavone or flavanone derivatives (especially flavonoids) to combat undesirable pigmentation of the skin is claimed.- MECHANISM OF ACTION -...
DE19834717A1 New composition containing flavonoid and Pfaffia plant product  
A composition containing a flavonoid and a processed product from a plant of the genus Pfaffia is new. The composition can also conveniently contain a processed product from a caffeine-containing...
DE4224781A1 (ALPHA) -GLYCOSYLQUERCETINE, PROCESS FOR THEIR PRODUCTION AND USE  
A novel alpha -glycosyl quercetin, wherein equimolar or more D-glucose residues are attached to quercetin via the alpha -bond, has a satisfiable water-solubility, light tolerance and stability,...
DE4107079A1 Rutin prepn. - by extn. of rutin-contg. materials with 1,4-dioxan and recrystallisation  
Prepn. of rutin comprises (a) extn. of rutin-contg. material of plant origin with 1,3-dioxan, and (b) recrystallisation. ADVANTAGE - The process gives Rutin of high purity and is suitable either...
DE4034586A1 Substd. 4-oxo-4H-benzopyran -3-O-beta-D-glucuronide derivs. prepn. - by converting myricetin to di:benzyl-myricetin-tetra:ethanoate which is saponified and then beta glycoside(s) and hydrogenated  
Prepn. of (3,5,7-trihydroxy-2- (3',4',5'-trihydroxyphenyl) -4-oxo- 4H-benzopyran)-3-0-beta-D- glucuronide derivs. (Ia) of formula (I) or their salts (Ib) or complexes (Ic) comprises (a) reacting...
DE3908749A1 Cardiovascular medicine  
Published without abstract.
DE3715447A1 Prepn. of mono: and di:beta-hydroxy-ethyl di:osmine mixt.  
A standard mixture of O-(beta-hydroxyethyl)- diosmines (I) is prepared by treating 1 mole of diosmine (II) with 4.5 moles of 2-chloroethanol in an aq. alkaline medium at 15-30 deg.C. (I) comprises...

Matches 1 - 23 out of 23